incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 48,223.12 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

The discovery sheds some light on a "lost" dynasty of pharaohs who ruled during a little-understood time in ancient Egypt's long history. Archaeologists from Egypt and the U.S. unearthed the tomb ...

GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first ...

GSK recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and the EMA's acceptance of an application for Nucala's expanded use. Despite these ...

GSK recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and the EMA's acceptance of an application for Nucala's expanded use. Despite these ...

Pfizer and GlaxoSmithKline have agreed to end a lawsuit over alleged patent infringement involving their competing respiratory syncytial virus (RSV) vaccines, according to a filing made in Delaware ...

Egypt and France have signed a 7 billion euro ($7.68 billion) agreement to develop finance and operate a green hydrogen production facility, Egypt's transportation ministry said. For all the ...

Egypt and France have signed a 7 billion euro ($7.68 billion) agreement to develop finance and operate a green hydrogen production facility, Egypt's transportation ministry said. The agreement was ...

On April 3, 2025, GlaxoSmithKline (GSK) and Pfizer filed a stipulation to dismiss with prejudice GSK’s litigation in the United States District Court for the District of Delaware. GSK filed suit ...

COLUMBUS, Ohio — Ohio Attorney General Dave Yost is pushing to take a leading role in a federal securities lawsuit that accuses pharmaceutical giant GSK, formerly GlaxoSmithKline, of concealing the ...

An Egyptian source told the newspaper Asharq Al-Awsat that the Egyptian proposal for an agreement with Hamas, presented to representatives of the terrorist organization, includes the release of ...

South Ko­re­an biotech ABL Bio has lined up an­oth­er plat­form li­cense agree­ment with a Eu­ro­pean phar­ma gi­ant in the area of neu­rode­gen­er­a­tive dis­eases.